Tandemly integrated HPV16 can form a brd4-dependent super-enhancer-like element that drives transcription of viral oncogenes

mBio

Volumn 7, Issue 5, 2016, Pages

  Dooley, Katharine E ^a   Warburton, Alix ^a   McBride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRD4 PROTEIN; HISTONE H3; MED1 PROTEIN; PROTEIN; PROTEIN E6; PROTEIN E7; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BRD4 PROTEIN, HUMAN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; HISTONE; MED1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; REPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENHANCER REGION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS ONCOGENE; VIRUS TRANSCRIPTION; BIOSYNTHESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEDIATOR COMPLEX SUBUNIT 1; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

EID: 84994406598     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01446-16     Document Type: Article

References (46)

1. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114. http://dx.doi.org/10.1038/314111a0
2. Jeon S, Allen-Hoffmann BL, Lambert PF. 1995. Integration of human papillomavirus type-16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989-2997
3. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broker TR, Moen PT, Jr., Chow LT. 2004. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78:11172-11186. http://dx.doi.org/10.1128/JVI.78.20.11172-11186.2004
4. McLaughlin-Drubin ME, Meyers J, Munger K. 2012. Cancer associated human papillomaviruses. Curr Opin Virol 2:459-466. http://dx.doi.org/10.1016/j.coviro.2012.05.004
5. Bhattacharjee B, Sengupta S. 2006. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354:280-285. http://dx.doi.org/10.1016/j.virol.2006.06.018
6. Sakakibara N, Mitra R, McBride AA. 2011. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol 85:8981-8995. http://dx.doi.org/10.1128/JVI.00541-11
7. Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, Archambault J. 2011. Nuclear accumulation of the papillo-mavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol 85:8996-9012. http://dx.doi.org/10.1128/JVI.00542-11
8. Jeon S, Lambert PF. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92:1654-1658. http://dx.doi.org/10.1073/pnas.92.5.1654
9. Dürst M, Croce CM, Gissmann L, Schwarz E, Huebner K. 1987. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A 84:1070-1074. http://dx.doi.org/10.1073/pnas.84.4.1070
10. McBride AA, Jang MK. 2013. Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses 5:1374-1394. http://dx.doi.org/10.3390/v5061374
11. You J, Croyle JL, Nishimura A, Ozato K, Howley PM. 2004. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117:349-360. http://dx.doi.org/10.1016/S0092-8674(04)00402-7
12. McPhillips MG, Ozato K, McBride AA. 2005. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol 79:8920-8932. http://dx.doi.org/10.1128/JVI.79.14.8920-8932.2005
13. Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, Harper JW, Howley PM. 2010. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci U S A 107:3752-3757. http://dx.doi.org/10.1073/pnas.0914818107
14. Wu SY, Lee AY, Hou SY, Kemper JK, Erdjument-Bromage H, Tempst P, Chiang CM. 2006. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20:2383-2396. http://dx.doi.org/10.1101/gad.1448206
15. Smith JA, Haberstroh FS, White EA, Livingston DM, DeCaprio JA, Howley PM. 2014. SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter. Virology 468-470: 311-321. http://dx.doi.org/10.1016/j.virol.2014.08.022
16. Yan J, Li Q, Lievens S, Tavernier J, You J. 2010. Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. J Virol 84:76-87. http://dx.doi.org/10.1128/JVI.01647-09
17. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153: 307-319. http://dx.doi.org/10.1016/j.cell.2013.03.035
18. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell 155:934-947. http://dx.doi.org/10.1016/j.cell.2013.09.053
19. Pott S, Lieb JD. 2015. What are super-enhancers? Nat Genet 47:8-12. http://dx.doi.org/10.1038/ng.3167
20. Lovén J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153:320-334. http://dx.doi.org/10.1016/j.cell.2013.03.036
21. Stanley MA, Browne HM, Appleby M, Minson AC. 1989. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 43:672-676. http://dx.doi.org/10.1002/ijc.2910430422
22. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K. 2003. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A 100:8758-8763. http://dx.doi.org/10.1073/pnas.1433065100
23. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE. 2010. Selective inhibition of BET bromodomains. Nature 468:1067-1073. http://dx.doi.org/10.1038/nature09504
24. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, Tarakhovsky A. 2010. Suppression of inflammation by a synthetic histone mimic. Nature 468:1119-1123. http://dx.doi.org/10.1038/nature09589
25. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. 2009. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog 5:e1000397. http://dx.doi.org/10.1371/journal.ppat.1000397
26. Jang MK, Shen K, McBride AA. 2014. Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome. PLoS Pathog 10:e1004117. http://dx.doi.org/10.1371/journal.ppat.1004117
27. Schweiger MR, Ottinger M, You J, Howley PM. 2007. Brd4 independent transcriptional repression function of the papillomavirus E2 proteins. J Virol 81:9612-9622. http://dx.doi.org/10.1128/JVI.00447-07
28. Chung CW, Coste H, White JH, Mirguet O, Wilde J, Gosmini RL, Delves C, Magny SM, Woodward R, Hughes SA, Boursier EV, Flynn H, Bouillot AM, Bamborough P, Brusq JM, Gellibert FJ, Jones EJ, Riou AM, Homes P, Martin SL. 2011. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem 54: 3827-3838. http://dx.doi.org/10.1021/jm200108t
29. Filippakopoulos P, Knapp S. 2014. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13:337-356. http://dx.doi.org/10.1038/nrd4286
30. Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. 2005. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19:523-534. http://dx.doi.org/10.1016/j.molcel.2005.06.027
31. Rahman S, Sowa ME, Ottinger M, Smith JA, Shi Y, Harper JW, Howley PM. 2011. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 31:2641-2652. http://dx.doi.org/10.1128/MCB.01341-10
32. Francis DA, Schmid SI, Howley PM. 2000. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J Virol 74:2679-2686. http://dx.doi.org/10.1128/JVI.74.6.2679-2686.2000
33. Goodwin EC, DiMaio D. 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A 97: 12513-12518. http://dx.doi.org/10.1073/pnas.97.23.12513
34. Thierry F, Yaniv M. 1987. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J 6:3391-3397
35. Wells SI, Aronow BJ, Wise TM, Williams SS, Couget JA, Howley PM. 2003. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc Natl Acad Sci U S A 100:7093-7098. http://dx.doi.org/10.1073/pnas.1232309100
36. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, Howley PM. 2000. Papillomavirus E2 induces senescence in HPV-positive cells via pRB-and p21(CIP)-dependent pathways. EMBO J 19:5762-5771. http://dx.doi.org/10.1093/emboj/19.21.5762
37. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D, Hwang ES. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci U S A 97:10978-10983. http://dx.doi.org/10.1073/pnas.97.20.10978
38. Schweiger MR, You J, Howley PM. 2006. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol 80:4276-4285. http://dx.doi.org/10.1128/JVI.80.9.4276-4285.2006
39. Bechtold V, Beard P, Raj K. 2003. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol 77:2021-2028. http://dx.doi.org/10.1128/JVI.77.3.2021-2028.2003
40. Helfer CM, Yan J, You J. 2014. The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation. Viruses 6:3228-3249. http://dx.doi.org/10.3390/v6083228
41. Groves IJ, Knight ELA, Ang QY, Scarpini CG, Coleman N. 15 February 2016. HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome. Oncogene http://dx.doi.org/10.1038/onc.2016.8
42. Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU. 2008. Effects of cellular differentiation, chromosomal integration and 5-aza-2=deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374:292-303. http://dx.doi.org/10.1016/j.virol.2007.12.016
43. Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison ML. 2014. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 24:185-199 http://dx.doi.org/10.1101/gr.164806.113
44. Chapman S, McDermott DH, Shen K, Jang MK, McBride AA. 2014. The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional. Stem Cell Res Ther 5:60. http://dx.doi.org/10.1186/scrt449
45. De Geest K, Turyk ME, Hosken MI, Hudson JB, Laimins LA, Wilbanks GD. 1993. Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol Oncol 49:303-310. http://dx.doi.org/10.1006/gyno.1993.1131
46. Sakakibara N, Chen D, Jang MK, Kang DW, Luecke HF, Wu SY, Chiang CM, McBride AA. 2013. Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA. PLoS Pathog 9:e1003777. http://dx.doi.org/10.1371/journal.ppat.1003777.